Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Katsuhiro Mihara, RPh, PhD is a registered pharmacist and with a PhD in pharmaceutical sciences from the University of Tokushima.
He joined Venn in 2016 to lead the Clinical Development department and is currently also leading Venn’s business in the Netherlands.
Before joining Venn, he held leadership and senior scientist positions in clinical development and pharmacology at Abbott, Merck Sharp and Dohme, Schering Plough and Organon, giving him over 25 years of experience in preclinical/early clinical drug development in big pharma, biotech and provider alike.
He has been involved in numerous drug development projects as project leader, clinical trial manger and/or study director in multiple therapeutic areas, including, but not limited to, oncology, immunology, dermatology, urology, gynaecology and CNS from early discovery to marketing.
His experiences also include due diligence of various drug development projects with primary focus on risk assessments including evaluation of regulatory documents at major milestones (e.g. pre-IND, End of Phase I/II meetings) for investors.
No articles found for this topic.
